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Background: We have demonstrated previously that NFKB1 single nucleotide polymorphism (SNP) rs4648068 GG
homozygote was associated with the increased risk of gastric cancer in Chinese Han population. In this study, we
constructed the recombinant plasmid pGL3-AA, pGL3-GG, pGL3-AA-NFKB and pGL3-GG-NFKB to investigate the
function of rs4648068 by cell biology experiments.
Methods: Quantitative real-time PCR was used to detect NFKB1 SNP rs4648068 genotype in the patients with gastric
cancer. Anti-NF-κB1 p50 polyclonal antibodies were used for immunohistochemical analysis of the tissue specimens.
The subsection of NFKB1 containing the promoter site and adjacent three consecutive exons were obtained by PCR
technique and subcloned into the vector pGL3-Basic. Dual-Luciferase reporter assay was used to detect the
transcriptional activity of the constructed promoter. Effects of transcription factor NFKB1 on C/EBPβ expression
were determined by chromatin immunoprecipitation and Western analysis. Furthermore, proliferation and invasion
ability of the transduced cell were also measured and compared.
Results: Intensive staining for p50 expression was observed in the tissues of GG genotype patients, compared with
those of GA group and AA genotype patients. The transcriptional activity of rs4648068 (A > G) by dual-Luciferase
reporter assay suggested that the luciferase activity of homozygote group (pGL3-GG) was greater than that of the
control (pGL3-AA), especially at the stimulation of LPS. We found that the luciferase activity was also influenced
by pGL3-GG levels. The effects of NFKB1 rs4648068 were enhanced by rs4648065 on the transduced cells. The
interaction between NFKB1 promoter nucleotide sequence and C/EBPβ was regulated by the functional SNP
rs4648068 in SGC-7901 cells. Our data indicated that the transduction of pGL3 expression plasmid pGL3-GG-NFKB
improved the proliferation and motility of gastric cancer cells. Correspondingly, the homozygote GG of SNP
rs4648068 strengthened the transcriptional activity of NFKB1 and influenced the cell biological activity.
Conclusion: The transcriptional activity of NFKB1 was associated with SNP rs4648068, and this functional SNP site
has the important effects on cell proliferation and motility.
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Nuclear factor-κB (NF-κB) regulates many cellular func-
tions including cell proliferation, apoptosis, angiogenesis,
immune response, cell adhesion and differentiation [1].
The signal pathway involved by NF-κB plays important
roles in linking inflammation to tumor development and
progression [2]. NF-κB family contains five members in
mammals: NFKB1 encoding p50, NFKB2 encoding p52,
RELA encoding p65, REL encoding c-Rel, and RELB en-
coding Rel-B. The most common dimer is the p65/p50
heterodimer, which is inhibited by IκB in the cytosol [3].
Internal gene mutations and external stimuli contribute
to the release of activated NF-κB [4]. The elevated NF-
κB levels have been reported to be associated with can-
cers [5-7].
Rs4648068 polymorphism locates at NFKB1 promoter
region. Polymorphisms in the regulatory regions of the
genes have been associated with variation in gene ex-
pression [8,9]. The rs4648068 polymorphism is hypothe-
sized to have a significant effect on NF-κB1 expression
and play a part in tumorigenicity.
In the previous case–control study, we have demon-
strated the role of NFKB1 rs4648068 polymorphisms in
gastric cancer susceptibility in Chinese Han population.
The results further indicated that the subjects with the
allelic homozygous GG in rs4648068 had an increased
risk in gastric cancer group compared with that in con-
trols (P = 0.005) [10]. However, the motility-promoting
function of this single nucleotide polymorphism (SNP)
site in gastric cancer progression is still uncertain. To
clarify the functional mechanisms of NFKB1 rs4648068
polymorphism, it is necessary to investigate the changes
of NF-κB1 expression at cellular and molecular levels.
Accordingly, the polymorphism rs4648068 might play a
role in the development of gastric cancer.
In this study, we constructed the recombinant plas-
mids, containing the different SNP variants to investi-
gate the changes on transcriptional activity of NFKB1.
Additionally, the growth and invasion alteration of trans-
duced cells was observed to further demonstrate the bio-
logical function of rs4648068 in gastric cancer.
Methods
Patients’ samples and cell lines
In previous study, we conducted a large-scale case–
control study on Chinese Han population to investigate
the association of rs4648068 polymorphism with gastric
cancer or clinic-pathologic variables of gastric cancer pa-
tients. To further verify its function, the expression
levels were measured with 20 tissues from gastric cancer
patients using immunohistochemical staining. Mean-
while, the genomic DNA of these patients was collected
to do genotyping. The study design was approved by
the Clinical Research Ethics Committee of the FudanUniversity Shanghai Cancer Center. All of the partici-
pants signed informed consent documents prior to par-
ticipating in this study. Paraffin-embedded gastric cancer
tissue samples were collected from 20 patients with
gastric cancer who were admitted to Fudan University
Cancer Hospital (Shanghai, China) July 2014. All cases
were gastric adenocarcinoma confirmed by pathologist.
Only the patients whose clinical data (include diagnosis,
age, sex, address, disease history, etc.) were intact were se-
lected. The gastric carcinoma cell lines, SGC-7901 cells,
MKN45 cells, HGC27 cells and the non-gastric cancer cell
lines, 293 T, Hela cells, were generous gifts from La-
boratory of Oncology, Fudan University Shanghai Cancer
Center, Shanghai.
Sample preparation and NFKB1 genotyping
Genomic DNA was extracted from peripheral blood
samples of each study subject using the TIANamp
Blood DNA Kit (Tiangen Biotech, China). NFKB1 SNPs
rs4648068 were genotyped by SYBR allelic discrimin-
ation. The corresponding qRT-PCR specific primers
pGL3-RTp1, pGL3-RTp2 and pGL3-RTp3 are listed in
Table 1. PCRs were run in a 10 μL reaction solution
containing 30 ng of template DNA, 5 μL SYBR Premix
Ex Taq (TAKARA, Japan) according to the manual.
PCR was performed at 95°C for 10 min and 40 cycles
at 95°C for 30 s and 58°C for 30 s. The samples were
amplified, read and analyzed in Option® Fluorescence
Temperature Cycler (MJ Research, Canada).
Immunohistochemical staining
Immunohistochemical staining was performed on 6-μm
sections from formalin-fixed, paraffin-embedded human
tissues. The slides were deparaffinized and rehydrated
ingraded ethanol solutions. Antigen retrieval was per-
formed by heating the samples for 20 min in citrate
buffer (pH 6.0). The slides were then incubated with a
rabbit anti-NF-κB p50 polyclonal antibody (1:100 dilu-
tion; ab7971, Abcam) overnight at 4°C. Tissue sections
were washed again in PBS and incubated with horse-
radish peroxidase-conjugated secondary antibodies for
60 min at 37°C. Color was developed using diamino-
benzidine as a chromogen and the slides were counter-
stained with hematoxylin.
Evaluation of immunohistochemical staining results
The NF-κB1 positive tissues were quantified based on
the percentage of positive cells which were serially
counted in one microscopic field. The cell counting was
repeated in five random microscopic fields at × 400 mag-
nification. Two pathologists who were blinded to patient
group independently interpreted the IHC staining results
using positive index (PI). The positive index (PI) was cal-
culated using the following formulation: PI = i × p, where
Table 1 Primers used in this study
Name Sequence Restriction enzyme
pGL3-RTp1 5′ TAA TTG TTA GAG ATT CCA A 3′
pGL3-RTp2 5′ TAA TTG TTA GAG ATT CCA G 3′






The restriction sites for primers are italics.
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weakly-positive, light yellow; 2 for medium positive, yel-
low; 3 for strong positive, brown), and p is positive per-
centage of staining (1 for ≦10%; 2 for 11%-50%; 3 for
51%-75%; 4 for >75%) [11]. Then, the positive index (PI)
was calculated for each case. If there were divergences
in the PI determined by the two pathologists, slides
were rescored until a consensus was reached. Besides,
differences in NF-kappaB1 expression between different
groups were investigated using Kruskal-Wallis non-
parametric test.
The construction of recombinant plasmid
The section containing NFKB1 promoter region with poly-
morphisms rs4648068 was obtained by PCR using primers
pGL-promoterFor1 and pGL-promoterRev (Table 1).
DNA templates were extracted from peripheral blood
samples of gastric cancer patients using the method de-
scribed above. The PCR products containing NFKB1 poly-
morphisms were digested by Bgl II and Kpn I and linked
into the vector pGL3-basic (Promega, Madison, WI) to
construct recombinant plasmid pGL3-AA and pGL3-GG.
Meanwhile, pGL3-GG/TT containing rs4648065 site was
established as above described method to investigate the
co-effect on rs4648068. Furthermore, the sequence coding
selected section of NF-κB1 was amplified to construct
the NF-kappaB expression plasmid according to the hu-
man NF-κB neclotides sequences (NM_001165412.1) in
GenBank. The CDS region containing adjacent three
consecutive exons was amplified using pGL-NFKBFor
and pGL-NFKBRev (Table 1), subcloned into pGL3-AA
and pGL3-GG, named as pGL3-AA-NFKB and pGL3-
GG-NFKB respectively, while the random DNA frag-
ments and above PCR products was subcloned into the
vector pGL3-basic to construct recombinant plasmid
pGL3-mock. The recombinant plasmids pGL3-AA and
pGL3-GG were constructed for luciferase assay, while
the expression plasmids pGL3-AA-NFKB and pGL3-
GG-NFKB were constructed for cell biological experi-
ment. Non-gastric cell lines such as 293 T cells and
Hela cells, gastric cancer cell lines such as MKN45cells, HGC27 cells and SGC7901, were transfected with
pGL3-AA and pGL3-GG using Lipofectamine 2000
(Invitrogen) respectively to verify the transcriptional ac-
tivity of NFKB1 promoter. The expression plasmids
were also transfected into SGC7901 cells, designated
as 7901-pGL3-mock, 7901-pGL3-AA, and 7901-pGL3-
GG. The PCR reactions were carried out at 94°C for
2 min, then a 3-step cycle procedure was used (de-
naturation at 94°C for 30s, annealing at 57.3°C for 40 s,
and elongation at 70°C for 3.5 min) for 39 cycles, with
a final extension at 72°C for 10 min.Transfection and luciferase assay
The luciferase assay is one of the most convenient re-
porter assays to explore the regulation of gene expres-
sion in mammalian cell culture. The pGL3-basic vector
only has the luciferase gene and lacks regulatory regions,
such as promoter sequences. This vector is useful in the
study of functional promoter elements to regulate gene
expression. Renilla luciferase pRL-SV40 vector was used
to normalize and reduce differences in transfection effi-
ciencies and subsequent variations in these experiments.
For our luciferase assays, approximately 7 × 104 of SGC-
7901 cells were cultured in a 24-well plate in antibiotic-
free media. After attachment, cells were co-transfected
with recombinant plasmids and pRL-SV40 vector by
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA).
Other cell lines, such as 293 T cells, Hela cells, MKN45
cells and HGC27 cells, were transfected with these
plasmids by the same method. LPS (100 ng/mL) was
added into wells of stimulation group 24 h later. After
48 h incubation with cell culture media, then cells were
lysed in passive lysis buffer (Promega, Wisconsin,
USA). Firefly and Renilla luciferase signals were mea-
sured by the Dual-Luciferase® Reporter Assay System
(Promega, Wisconsin, USA) in Synergy H4 Hybrid Mi-
croplate Reader (BioTek, Winooski, USA). Relative lu-
ciferase activity (Luc) calculated by the ratio of Firefly
and Renilla luciferase signals was used to monitor the
efficiency of transfection.
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Five million SGC-7901 cells were cross-linked with 1%
formaldehyde at room temperature for 10 min. Chroma-
tin extracts were obtained by cell lysis buffer. Sonication
was performed 14 times for 4.5 s each at Power 25%
(Thermo™, Ultrasonic Cell Disruptor, Model XL) result-
ing in DNA fragments between 150 and 1000 bp in size.
Supernatants were collected and submitted to immuno-
precipitation with 5 μg of rabbit anti-C/EBPβ polyclonal
antibody (sc-150X, Santa Cruz Biotechnology) and 20 μl
of magnetic protein A/G beads (Magna ChIP™ A/G,
Millipore, USA) overnight at 4°C. In parallel, superna-
tants were incubated with normal rabbit IgG antibody as
negative controls. Protein A/G magnetic beads were
washed and pelleted by magnetic separator, and heated
in ChIP Elution Buffer with Proteinase K at 65°C for
2 hours to reverse the cross-links of protein/DNA com-
plexes. DNA fragments were purified on offered Spin
columns. Finally, 4 μl from a 30 μl extraction were PCR
amplified for NFKB1 promoter genes using the primers
pGL-promoterFor1 and pGL-promoterRev (Table 1).
Western blot analysis
The rabbit anti-p50, anti-GAPDH antibody and the
secondary antibody were purchased from Abcam
(Cambridge, MA, USA). The C/EBPβ polyclonal anti-
body was purchased from Santa Cruz Biotechnology
(Santa Cruz Biotechnology, CA, USA). Cultured cells were
washed with phosphate-buffered saline and lysed on ice
for 30 min with 500 μL lysis buffer (Beyotime, China). The
cell lysate was centrifuged at 4°C at 10,000 × g for 15 min.
The supernatant nuclear protein was used for Western
blot. Twenty micrograms of cell extracts was loaded into
12% sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis and subjected to Western blot. GAPDH was used
as the internal control. Enhanced chemiluminescence de-
tection was performed according to the manufacturer’s
instructions using X-photo film (Alpha Innotech, San
Leandro, CA) and chemiluminescent substrate (Thermo
Scientific, Rockford, IL).
Cell proliferation and invasion assay
For the cell proliferation assay, 7901-pGL3-mock, 7901-
pGL3-AA and 7901-pGL3-GG cells were grown at a
density of 7 × 104 cells/mL in 24-well plates with regular
medium changes. The cell number was counted every
24 hours for 6 days as follows: cells were detached
by brief exposure to 0.025% trypsin containing 2 mM
EDTA in PBS, washed in culture medium without FBS,
and then resuspended in the same medium for manual
cell counting. For the invasion assays, matrigel was
thawed at 4°C overnight, diluted in cold serum-free cul-
ture medium, plated onto 24-well plates preloaded with
Transwell™ culture inserts (12 mm diameter, 8 μm poresize; Costar, Cambridge, MA, USA) and incubated for
5 h at 37°C for gelling. The cells were then plated onto
the Transwell™ inserts (30,000 cells/well) and cultured at
37°C in 5%CO2. After 16 h, the cells on the upper side
of the well were removed and fixed prior to staining with
hematoxylin and eosin. Cells migrating to the underside
were counted under a microscope. All experiments were
repeated at least three times.
Apoptosis assay
SGC-7901 cells were transfected with pGL3-AA-NFKB
and pGL3-GG-NFKB respectively. At 48 h after trans-
fection, cells were collected and resuspended in binding
buffer containing Annexin V-PE and PI (BD Pharmingen,
La Jolla, CA). Cell-associated fluorescence was analyzed
with a FACS can instrument and associated Winlist 5
software.
Statistical analysis
For immunohistochemistry PI of NF-κB1 expression,
data were analyzed by Kruskal-Wallis non-parametric
tests. The difference in the levels of luciferase reporter
gene expression between different groups was deter-
mined by Student’s t test and One-way ANOVA analysis
(SPSS version 13.0; SPSS Inc., Chicago). Differences be-
tween variants were considered significant at P < 0.05.
Results
Expression of NF-κB1 in gastric cancer tissues
In previous study, we conducted a large-scale case–
control study on Chinese Han population to investigate
the association of rs4648068 polymorphism with gastric
cancer or clinic-pathologic variables of gastric cancer
patients. To further verify its expression profile, 20 tissues
from gastric cancer patients were analyzed by immunohis-
tochemical staining. The corresponding genomic DNA
of these patients was also performed genotyping ana-
lysis. Our data showed that the NF-κB1 protein p50
was located in both the cytoplasm and nuclei of gastric
cancer tissues. Diffuse staining for p50 was observed in
the tissues of GG genotype patients, compared with the
GA group and the AA group (Figure 1). The immuno-
histochemistry PI of NF-κB1 expression for GG group
was significantly higher than those of GA group and
AA group, analyzed by Kruskal-Wallis non-parametric
test (P < 0.01).
The construction and identification of recombinant
plasmid
The promoter region containing NFKB1 polymorphisms
rs4648068 (A >G) was subcloned into the vector pGL3-
basic successfully. The recombinant plasmids were named
as pGL3-AA and pGL3-GG. In addition, pGL3-GG/TT
containing SNP rs4648065 (C > T) was established using
Figure 1 (See legend on next page.)
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Figure 1 Expression of NF-κB1 in gastric cancer tissues. A. The staining results were shown. NF-κB1 (brown) is mainly expressed in
cytoplasm of gastric adenocarcinoma tissue. (a) The patients’ genotype was GG. Dark brown NF-κB1 cytoplasm staining was observed. (b) The
patients’ genotype was AA. NF-κB1 immunohistochemical staining of AA group exhibited faint. (c) The patients’ genotype was GA. NF-κB1
immunohistochemical staining was also faint. Left panels magnification, ×200; Right panels magnification, ×400. B. Differences in NF-kappaB1
expression between different groups were invcestigated using Kruskal-Wallis non-parametric test. The immunohistochemistry PI of NF-κB1
expression for GG group was significantly higher than those of GA group and AA group (P < 0.01). ***P < 0.01, **P < 0.05.
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rs4648068. Furthermore, adjacent three consecutive
exons for NF-κB1 was amplified and subcloned into
pGL3-AA and pGL3-GG respectively, named as pGL3-
AA-NFKB and pGL3-GG-NFKB. Nucleotide sequence
further confirmed that the sequence of recombinant plas-
mid was correct without base mutation and deletion, and
the sequence inserted was corrected by comparing with
GenBank as is shown in Figure 2. Subsequently, weFigure 2 The recombinant plasmid was identified by nucleotide sequ
exons for NF-κB1 were subcloned to the pGL3-basic vector. Triangles abov
arrows indicate the three exons for NF-κB1 (from ATG to TAA, altogether 1
base mutation and deletion, and the sequence inserted was corrected by cconfirmed that the recombinant luciferase could be
expressed in the transduced cells.
Gene expression activity was associated with NFKB1
polymorphisms
To examine the functional activity of NFKB1 promoter
variations A >G (rs4648068), as well as the synergistic ef-
fect by C > T (rs4648065), which was described in our pre-
vious study, different recombinant plasmids containingence. Map showed that the promoter region and three consecutive
e the map indicate the position of NF-κB1 promoter, and the bent
254 bp). The sequence of recombinant plasmid was correct without
omparing with GenBank.
Chen et al. BMC Gastroenterology  (2015) 15:21 Page 7 of 12homozygote site were transiently transduced for transcrip-
tional activity evaluation, 48-hours after transfection,
renilla and firefly luciferase activities were measured. For
non-gastric cell lines, luciferase activity for GG homozy-
gote (4.53 ± 0.81) were higher than that of AA homozy-
gote (1.94 ± 0.37) in 293 T cells (P = 0.041). In Hela cells,
the luciferase activity for GG homozygote (7.09 ± 0.91)
were also greater, compared with that of AA homozygote
(1.97 ± 0.38, P = 0.002). For gastric cell lines, the luciferase
expression ratios (7.12 ± 0.68 for MKN45 cells, 5.80 ± 0.42
for HGC27 cells, and 8.80 ± 0.64 for 7901 cells) in GG
homozygote were observed higher than AA homozygote
(3.56 ± 0.67 for MKN45 cells, 3.09 ± 0.43 for HGC27 cells,
and 3.36 ± 0.30 for 7901 cells; P = 0.022, P = 0.04 and P =
0.004, respectively) with significant difference (Figure 3A).
Moreover, two homozygote GG/TT panel for gastric cell
lines (11.23 ± 0.38 for HGC27 cells, and 11.52 ± 0.15 for
7901 cells) showed stronger luciferase activity than that of
homozygote GG panel (5.80 ± 0.42 for HGC27 cells, and
8.80 ± 0.64 for 7901 cells; P = 0.001, P =0.038 respectively)
(Figure 3B). The result showed that the luciferase activity
of homozygote group (pGL3-GG) was greater than con-
trol group (pGL3-AA) (P <0.05) (Figure 3A). Moreover,
the luciferase activity of two homozygote site groupFigure 3 NFKB1 polymorphisms significantly influenced luciferase ge
cell lines transfected with recombinant plasmid (pGL3-GG) was compared
cell lines transfected with (pGL3-GG/TT) was assessed to identify the synerg
independent experiments. The difference was determined by One-way AN(pGL3-GG/TT) was the strongest with significant differ-
ence in Figure 3B (P <0.05). The difference was deter-
mined by One-way ANOVA analysis (SPSS version 13.0;
SPSS Inc., Chicago). It indicated that SNP rs4648068 sig-
nificantly influenced luciferase gene expression in various
cell lines. In addition, we found that the effect of NFKB1
polymorphism rs4648068 was enhanced by polymorphism
rs4648065.
The effect of NFKB1 rs4648068 influenced by LPS
stimulation
The bacterial product LPS plays a role in the NF-κB sig-
naling pathway. Thus, we investigated the effect of NFKB1
rs4648068 on LPS-stimulated luciferase activity. Both of
recombinant plasmid pGL3-AA and pGL3-GG containing
the promoter region were transduced to SGC7901 cells.
The difference between luciferase activities of GG and AA
reporters was estimated under the stimulation of LPS
(Table 2). In the control group without LPS stimulation,
the relative luciferase activity of pGL3-GG was greater
than that of pGL3-AA, and the most effective concentra-
tion of recombinant plasmid was 100 ng/mL. Under the
stimulation of LPS, the increased range of relative lucifer-
ase activity was elevated greatly. To compare the luciferasene expression in various cell lines. A. Luciferase activity in various
with control group (pGL3-mock and pGL3-AA). B. Luciferase activity in
istic effect by rs4648065. Data are representative of at least three
OVA analysis (SPSS version 13.0; SPSS Inc., Chicago). **P < 0.05.
Table 2 The increased luciferase activity in LPS-stimulated
SGC-7901 cells and control cells
The increased luciferase activityΔ of recombinant plasmid
Group 25 ng/mL 50 ng/mL 100 ng/mL 150 ng/mL
Control 0.34 ± 0.03 0.91 ± 0.23 1.77 ± 0.53** 1.19 ± 0.36
LPS 2.86 ± 0.17# 4.54 ± 0.19# 5.32 ± 0.27# 5.74 ± 0.44#
Control group, unstimulated transduced cells; Δ, increased Luc = Luc (GG)-Luc
(AA); #, P < 0.01, compared with control group respectively (Student’s t test);
**, P < 0.05, compared with other concentration levels (25 ng/mL, 50 ng/mL
and 150 ng/mL) (One-way ANOVA.).
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stimulated group was more obvious than the control
group with significant difference, analyzed by Student’s t
test (Table 2). It suggested that the SNP rs4648068 can en-
hance the transcriptional activity of NFKB1, especially in
LPS response.
Effects of polymorphisms on protein expression
C/EBPβ (CAAT/enhancer binding proteins) is a tran-
scription factor that can bind as a homodimer to certain
DNA regulatory regions. To further define the role ofFigure 4 NFKB1 polymorphisms influenced protein expression in pla
ChIP of C/EBPβ on the NFKB1 promoter was shown. B. Western blotting s
7901-pGL3-GG cells, compared with 7901- pGL3-AA cells. The gray value was
clarify the interaction between NFKB1 promoter and C/EBPβ.rs4648068, chromatin immunoprecipitation assay (ChIP)
was used to investigate the interaction between C/EBPβ
and NFKB1 promoter in the SGC-7901 cell. The recom-
binant plasmid pGL3-AA-NFKB and pGL3-GG-NFKB,
which contain the promoter region of NFKB1 and adja-
cent three consecutive exons, were transduced to the
SGC-7901 cells, recognized as 7901-pGL3-AA cells and
7901-pGL3-GG cells. We found, as expected, that C/EBPβ
bound to the NFKB1 promoter containing the SNP site
(Figure 4A). Meanwhile, western blotting showed a higher
level of p50 and C/EBPβ expression in 7901-pGL3-GG
cells, compared with those of 7901-pGL3-mock cells and
7901- pGL3-AA cells (Figure 4B). It seems that C/EBPβ
binds better to the GG version of NFKB1 promoter and
enhances the transcription of NFKB1. On the other hand,
NF-κB1 p50 could bind C/EBPβ and reciprocally induce
partner’s expression, forming a transcriptional positive
feedback loop, contributing to the upregulated p50 and C/
EBPβ expression (Figure 4C). Since NF-κB1, as well as C/
EBPβ, plays a role in the cell proliferation, differentiation,
signaling pathway and the occurrence of tumors. The SNP
site rs4648068 might have effect on cell proliferation andsmid transfected SGC-7901 cell. A. A representative gel result of
howed a higher level of NF-κB1 and C/EBPβ protein expression in
analyzed by One-way ANOVA. **P < 0.05. C. A diagram was shown to
Figure 5 (See legend on next page.)
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Figure 5 The SNP rs4648068 influenced cell proliferation, apoptosis percentage and invasive ability. A. Cell proliferation was significantly
elevated in 7901-pGL3-GG cells compared with 7901-pGL3-AA cells and 7901-pGL3-mock cells. B. In each box, the lower left corner included viable
cells, which were both Annexin V-FITC and PI negative. In the upper left corner, cells are in early apoptosis with Annexin V-FITC positive and
PI negative. While the upper right corner included necrotic or late apoptotic cells are both FITC Annexin V and PI positive. In 7901-pGL3-GG
cells, the percentage of apoptosis cells decreased significantly, compared with 7901-pGL3-AA. C. The invasion ability was increased in 7901-pGL3-GG
cells (c) than control cells (a, b). 200×. a, 7901-pGL3-AA cells; b, 7901-pGL3-mock cells; c, 7901-pGL3-GG cells. Data were assessed by One-way ANOVA
analysis. ***P < 0.01; **P < 0.05.
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mechanism for regulating C/EBPβ expression remains un-
clear, and will be performed in our future work.
Proliferation and invasion ability of transfected SGC-7901
cells
To further analyze the cell biological function of SNP
rs4648068, we conducted proliferation and invasion assay
in transfected SGC-7901 cells. Proliferation was assessed
by cell counting under an optical microscope for six
days. The proliferative rate of 7901-pGL3-GG cells was
observed faster than 7901-pGL3-AA cells and 7901-
pGL3-mock cells (Figure 5A). For the invasion assay,
7901-pGL3-GG cells showed a higher ability to migrate,
compared with 7901-pGL3-AA cells and 7901-pGL3-
mock cells (Figure 5C). It illustrated that the proliferation
and invasiveness of SGC-7901 was enhanced by transfec-
tion of the recombinant plasmid containing SNP site. To
guarantee the effective transduction, all the experiments
were completed within six days after the transfection.
Apoptosis assay
SGC-7901 cells were transfected with pGL3-AA-NFKB
and pGL3-GG-NFKB respectively. At 48 h after transfec-
tion, cells were collected and resuspended in binding
buffer containing Annexin V-FITC and PI, and then
processed for flow cytometry analysis. In 7901-pGL3-GG
cells, the percentage of apoptosis cells decreased signifi-
cantly, compared with 7901-pGL3-AA cells (Figure 5B).
The result demonstrated that in certain situations NF-κB1
acts as an anti-apoptotic protein.
Discussion
Our previous study indicated that NFKB1 polymorphism
at intron region (rs4648068) was associated with increased
risk of gastric cancer in Chinese Han population. The
present study focused on the investigation of NFKB1 tran-
scriptional activity and biological function influenced by
rs4648068 (A >G) polymorphism.
It was reported that NF-κB is constitutively activated in
gastric carcinoma tissue [12]. Kwon HC et al. [13] demon-
strated that the expression of NF-κB is increased in hu-
man gastric cancer tissue. The nuclear translocation of Rel
A (used as a marker of NF-κB activation) was significantly
greater in gastric cancer cells than in adjacent normalepithelial cells [14]. Yamanaka et al. [15] reported that gas-
tric cancer patients with high levels of NF-κB expression
had a lesser overall survival than patients with low levels
of NF-κB. The evidence presented above suggested that
NF-κB play an important role in the genesis and pro-
gression of gastric cancer. Moreover, immunohistochemi-
cal staining experiments were conducted to determine
in-depth relationship between NF-κB1 expression and
SNP site rs4648068. NF-κB1 p50 was found highly
expressed in the homozygote GG group compared with
the control group. It indicated that the functional site
has effects on NFKB1 transcriptional activity and regu-
lates its expression.
The luciferase assay is one of the techniques to study
the regulation of gene expression in mammalian cell cul-
ture [16,17]. The transcriptional activity could be assessed
by calculating the relative luciferase activity of plasmid
transfected cells [18]. For luciferase assays, our results
showed that the transcriptional activity of NFKB1 was
influenced by SNP rs4648068 at gene expression levels.
Moreover, the effect on rs4648068 by rs4648065 was also
observed at gene transcriptional activity. Our data sug-
gested that rs4648068 GG may upregulate the expression
of NFKB1, especially under the influence of rs4648065.
According to our data, the SNP rs4648068 can en-
hance the transcriptional activity of NFKB1, especially in
LPS response. This indicated that the effect of NFKB1
rs4648068 could be influenced by LPS stimulation. Under
the LPS stimulation, subsequent reaction occurs through
toll-like receptor (TLR)-4-induced signal transduction,
which then targets down-stream NF-κB pathway [19]. The
activation of NF-κB was affected by LPS stimulation [20].
Similarly, the effect of polymorphism rs4648068 on NF-
κB1 expression could be strengthened by LPS stimulation.
Liu et al. reported that various SNPs of cancer related
genes are associated with a faster progression of cancers
[21]. Polymorphisms in the promoter regions of genes
might potentially modulate the gene expression which in
turn influence the cell biological activity [18,22]. CHIP
assay provided evidence indicating that C/EBPβ can bind
to the NFKB1 promoter containing the SNP site [23], We
considered that, C/EBPβ bound better to the GG version
of NFKB1 promoter and enhanced the transcription of
NFKB1, giving rise to the upregulated p50 expression. In
addition, NF-κB1 p50 could bind C/EBPβ and reciprocally
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tional positive feedback loop. In fact, C/EBPβ was also
confirmed upregulated in the homozygote GG group, ac-
companied with a higher level of NF-κB1. The mechanism
for regulating C/EBPβ expression remains unclear, and
will be performed in our future work. C/EBPβ:p50 inter-
action could induce target genes to influence the cell bio-
logical activity [25]. Consequently, the SNP site rs4648068
might influence the cell biological activity by regulating
NF-κB1 and C/EBPβ expression.
The NFKB1 polymorphism (rs4648068) was found asso-
ciated with the cell proliferation and motility in gastric
cancer in this study. For the proliferation and invasion
assay, the result showed difference in biological activity
between transfected cells and control cells. 7901-pGL3-
GG cells showed increased ability of growth and inva-
sion, compared with 7901-pGL3-AA cells. For the
apoptosis assay, the percentage of apoptosis cells for
7901-pGL3-GG cells decreased significantly, compared
with 7901-pGL3-AA cells. The finding suggested that
SNP rs4648068 may play a role in regulating gastric
cancer cell biological activity.
In this study, we have demonstrated that the NFKB1
polymorphism (rs4648068) is associated with the cell pro-
liferation and motility in gastric cancer. The underlying
cellular and molecular mechanisms involve related signal-
ing pathway, such as NF-κB pathway and MAPK pathway.
MAPK pathway, as well as NF-κB pathway, is considered
the major signaling pathway induced by mediator such as
LPS. In the MAPK family, p38 MAPK, c-JNK and ERKs
are the most important components. The role of NFKB1
polymorphism (rs4648068) in the regulation of the gene
described above should be further studied.
Conclusions
In summary, the data presented confirmed that the tran-
scriptional activity of NFKB1 was associated with SNP
rs4648068. In addition, the functional activity of SNP
site was verified by cell biology experiment.
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